Evidence map›Paper›PMID 32104531›Full record

ArticleOxidative medicine and cellular longevity2020

Novel Fluorescent Mitochondria-Targeted Probe MitoCLox Reports Lipid Peroxidation in Response to Oxidative Stress

Konstantin G Lyamzaev, Alisa A Panteleeva, Anna A Karpukhina, Ivan I Galkin, Ekatherina N Popova, Olga Yu Pletjushkina, Bettina Rieger, Karin B Busch, Armen Y Mulkidjanian, Boris V Chernyak

Abstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review of optical reporters of radiation effectsJournal of biomedical optics · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Programmed cell death, redox imbalance, and cancer therapeutics.Apoptosis : an international journal on programmed cell death · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Konstantin G LyamzaevBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia.ORCID https://orcid.org/0000-0001-9921-8031
Alisa A PanteleevaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia.
Anna A KarpukhinaDepartment of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow 119992, Russia.
Ivan I GalkinBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia.ORCID https://orcid.org/0000-0002-9025-3794
Ekatherina N PopovaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia.ORCID https://orcid.org/0000-0002-7521-7736
Olga Yu PletjushkinaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia.
Bettina RiegerInstitute of Molecular Cell Biology, Department of Biology, University of Muenster, D-48149 Muenster, Germany.ORCID https://orcid.org/0000-0002-2726-4749
Karin B BuschInstitute of Molecular Cell Biology, Department of Biology, University of Muenster, D-48149 Muenster, Germany.ORCID https://orcid.org/0000-0003-0525-0191
Armen Y MulkidjanianBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia.ORCID https://orcid.org/0000-0001-5844-3064
Boris V ChernyakBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow 119992, Russia.ORCID https://orcid.org/0000-0003-1523-0864

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new mitochondria-targeted probe MitoCLox was designed as a starting compound for a series of probes sensitive to cardiolipin (CL) peroxidation. Fluorescence microscopy reported selective accumulation of MitoCLox in mitochondria of diverse living cell cultures and its oxidation under stress conditions, particularly those known to cause a selective cardiolipin oxidation. Ratiometric fluorescence measurements using flow cytometry showed a remarkable dependence of the MitoCLox dynamic range on the oxidation of the sample. Specifically, MitoCLox oxidation was induced by low doses of hydrogen peroxide or organic hydroperoxide. The mitochondria-targeted antioxidant 10-(6'-plastoquinonyl)decyltriphenyl-phosphonium (SkQ1), which was shown earlier to selectively protect cardiolipin from oxidation, prevented hydrogen peroxide-induced MitoCLox oxidation in the cells. Concurrent tracing of MitoCLox oxidation and membrane potential changes in response to hydrogen peroxide addition showed that the oxidation of MitoCLox started without a delay and was complete during the first hour, whereas the membrane potential started to decay after 40 minutes of incubation. Hence, MitoCLox could be used for splitting the cell response to oxidative stress into separate steps. Application of MitoCLox revealed heterogeneity of the mitochondrial population; in living endothelial cells, a fraction of small, rounded mitochondria with an increased level of lipid peroxidation were detected near the nucleus. In addition, the MitoCLox staining revealed a specific fraction of cells with an increased level of oxidized lipids also in the culture of human myoblasts. The fraction of such cells increased in high-density cultures. These specific conditions correspond to the initiation of spontaneous myogenesis

Indexed as

AnimalsCardiolipinsHumansHydrogen PeroxideLipid MetabolismLipid PeroxidationMicroscopy, FluorescenceMitochondriaMuscle DevelopmentOxidation-ReductionOxidative StressPlastoquinone10-(6'-plastoquinonyl)decyltriphenylphosphoniumCardiolipinsHydrogen PeroxidePlastoquinone

Identifiers

PMID32104531
PMCPMC7035557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.